Literature DB >> 20432450

Enhanced islet expansion by beta-cell proliferation in young diabetes-prone rats fed a protective diet.

Gen-Sheng Wang1, Lisa M Kauri, Christopher Patrick, Mirella Bareggi, Lawrence Rosenberg, Fraser W Scott.   

Abstract

Type 1 diabetes is inhibited in diabetes-prone BioBreeding (BBdp) rats fed a low-antigen hydrolyzed casein (HC) diet. In cereal-fed BBdp rats, islet expansion is defective accompanied by a futile upregulation of islet neogenesis without increased islet mass, due to a subtle blockage in islet cell cycle. We hypothesized that islet growth is enhanced before insulitis in HC-fed young BBdp rats and that islet neogenesis could be stimulated by a trophic factor, islet neogenesis-associated protein (INGAP). beta-Cell homeostasis was analyzed using immunohistochemistry, morphometry, laser capture microdissection and RT-PCR in BBdp rats fed HC or cereal diets. beta-cell proliferation in small and medium islets, and the number and area fraction of medium and large islets were increased in HC-fed animals. In situ islet cell cycle analysis revealed an increased proportion of proliferating S + G2 cells in medium and large islets of 25-45 day HC-fed rats. Expression of the cell cycle inhibitor, p16(INK4a) correlated with islet size and the percentage of p16(INK4a+) beta-cells increased in HC-fed BBdp rats, likely reflecting an increase in large islet area fraction. In HC-fed rats, extra-islet insulin(+) clusters (EIC), insulin(+) duct cells, large islet area fraction, and beta-cell mass were increased. Neurogenin-3 and Pdx-1, markers of beta-cell progenitors, were increased in EIC of weanling HC-fed rats. Daily injection of INGAP (30-45 days) increased the number of small islets, total islets, and insulin(+) cells in small ducts. Thus, in BBdp rats fed a protective HC diet, beta-cell expansion is enhanced through increased beta-cell proliferation and stimulation of islet neogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20432450     DOI: 10.1002/jcp.22151

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

1.  Antibodies from a patient with type 1 diabetes and celiac disease bind to macrophages that express the scavenger receptor CD163.

Authors:  Brigitte Sonier; Alexander Strom; Gen-Sheng Wang; Christopher Patrick; Jennifer A Crookshank; Majid Mojibian; Amanda J MacFarlane; Fraser W Scott
Journal:  Can J Gastroenterol       Date:  2011-06       Impact factor: 3.522

2.  Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes.

Authors:  Anne Jörns; Tanja Arndt; Andreas Meyer zu Vilsendorf; Jürgen Klempnauer; Dirk Wedekind; Hans-Jürgen Hedrich; Lorella Marselli; Piero Marchetti; Nagakatsu Harada; Yutaka Nakaya; Gen-Sheng Wang; Fraser W Scott; Conny Gysemans; Chantal Mathieu; Sigurd Lenzen
Journal:  Diabetologia       Date:  2013-12-06       Impact factor: 10.122

3.  Gut immune deficits in LEW.1AR1-iddm rats partially overcome by feeding a diabetes-protective diet.

Authors:  Jennifer A Crookshank; Christopher Patrick; Gen-Sheng Wang; J Ariana Noel; Fraser W Scott
Journal:  Immunology       Date:  2015-03-29       Impact factor: 7.397

Review 4.  From genetic association to molecular mechanism.

Authors:  Martijn van de Bunt; Anna L Gloyn
Journal:  Curr Diab Rep       Date:  2010-12       Impact factor: 4.810

5.  Dysregulated insulin secretion is associated with pancreatic β-cell hyperplasia and direct acinar-β-cell trans-differentiation in partially eNOS-deficient mice.

Authors:  Michela Novelli; Matilde Masini; Cecilia Vecoli; Stefania Moscato; Niccola Funel; Anna Pippa; Letizia Mattii; Chiara Ippolito; Daniela Campani; Danilo Neglia; Pellegrino Masiello
Journal:  Physiol Rep       Date:  2022-08

6.  Promotion of autoimmune diabetes by cereal diet in the presence or absence of microbes associated with gut immune activation, regulatory imbalance, and altered cathelicidin antimicrobial Peptide.

Authors:  Christopher Patrick; Gen-Sheng Wang; David E Lefebvre; Jennifer A Crookshank; Brigitte Sonier; Chandra Eberhard; Majid Mojibian; Christopher R Kennedy; Stephen P J Brooks; Martin L Kalmokoff; Mariantonia Maglio; Riccardo Troncone; Philippe Poussier; Fraser W Scott
Journal:  Diabetes       Date:  2013-01-24       Impact factor: 9.461

Review 7.  Pancreatic β Cell Mass Death.

Authors:  Husnia I Marrif; Salma I Al-Sunousi
Journal:  Front Pharmacol       Date:  2016-04-06       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.